Tony Casciano

Tony was appointed as Chief Commercial Officer at Viridian in 2023 to establish and lead all functions and activities related to commercialization.

Tony joins having formerly served as the COO & CCO of AMAG Pharmaceuticals, where he oversaw all commercial activities, as well as technical operations, global supply chain, corporate planning, and information technology. During his 4 years at AMAG Tony led the turnaround of the hematology oncology franchise and several successful product launches in highly competitive specialty and orphan disease markets, including infused products and SC autoinjectors. Prior to AMAG, he spent 16 years leading various commercial functions with increasing levels of responsibility at Sanofi and Genzyme. Most recently, Tony was serving as CEO of an MIT medical device spinout, where he successfully led and closed a Series A financing. 

He holds a bachelor’s degree in exercise science from Bridgewater State University and executive certificates in Marketing from the Wharton School of the University of Pennsylvania and in Governance from the Kellogg School of Management at Northwestern University.